Treatment of Portal Vein Tumor Thrombosis of Hepatoma Patients with Either Stereotactic Radiotherapy or Three-Dimensional Conformal Radiotherapy | Zendy

ChunShu Lin | Zendy; YeeMin Jen | Zendy; Su-Yun Chiu | Zendy; JingMin Hwang | Zendy; HsingLung Chao | Zendy; Hon-Yi Lin | Zendy; WengYoon Shum | Zendy

Open Access

Treatment of Portal Vein Tumor Thrombosis of Hepatoma Patients with Either Stereotactic Radiotherapy or Three-Dimensional Conformal Radiotherapy

Author(s) -

ChunShu Lin,

YeeMin Jen,

Su-Yun Chiu,

JingMin Hwang,

HsingLung Chao,

Hon-Yi Lin,

WengYoon Shum

Publication year - 2006

Publication title -

japanese journal of clinical oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.768

H-Index - 85

eISSN - 1465-3621

pISSN - 0368-2811

DOI - 10.1093/jjco/hyl006

Subject(s) - medicine , hepatocellular carcinoma , stereotactic radiotherapy , contraindication , radiation therapy , portal vein thrombosis , portal vein , thrombosis , radiology , surgery , nuclear medicine , radiosurgery , alternative medicine , pathology

Patients with hepatocellular carcinoma (HCC) often have unresectable tumors. Transcatheter arterial chemoembolization (TACE) is one of the limited alternative treatments that can prolong these patients' survival. However, the presence of portal vein tumor thrombosis (PVTT) is a contraindication for TACE and, therefore, HCC patients with PVTT would be depleted of the advantage of TACE. The purpose of this study was to analyze the recanalization rate of thrombosed portal vein and treatment toxicities after stereotactic radiotherapy (SRT) or three-dimensional conformal radiotherapy (3DCRT).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research